LOS ANGELES, Dec. 15, 2020 /PRNewswire/ -- Westlake Village BioPartners today announced the launch of two new funds totaling $500 million to build and invest in promising life sciences companies with transformative human therapeutic technologies. The first fund, known as Opportunity 1, is $70 million and allows Westlake to invest additional Series B or later-round capital […]
